研究業績

(1)原著

1)Yamaguchi Y, Wada M, Tanji H, Kurokawa K, Kawanami T, Ohtake H, Kato T: Marked improvement in opsoclonus and cerebellar ataxia after the surgical removal of squamous cell carcinoma of the thymus: A case report. J Neurol Sci. 2013; 325(1-2): 156-159

2)Tajima K, Yamamoto H, Yamamoto M, Kato Y, Kato T: Adult-onset arterial thrombosis in a pedigree of homozygous and heterozygous protein C deficiency. Thromb Res. 2013; 131（1）: 102-104

3)Kaino W, Daimon M, Sasaki S, Karasawa S, Takase K, Tada K, Wada K, Kameda W, Susa S, Oizumi T, Fukao A, Kubota I, Kayama T, Kato T: Lower physical activity is a risk factor for a clustering of metabolic risk factors in non-obese and obese Japanese subjects: the Takahata study. Endocr J. 2013; 60(5): 617-628

4)Tanji H, Koyama S, Wada M, Kawanami T, Kurita K, Tamiya G, Saito N, Suzuki K, Kato T, Anderson KE, Gruber-Baldini AL, Fishman PS, Reich SG, Weiner WJ, Shulman LM: Comparison of caregiver strain in Parkinson's disease between Yamagata,Japan, and Maryland, The United States. Parkinsonism Relat Disord. 2013; 19(6): 628-633

5)Hara S, Arawaka S, Sato H, Machiya Y, Cui C, Sasaki A, Koyama S, Kato T: Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner. Mol Biol Cell. 2013; 24(11): 1649-1660

6)Iseki C, Takahashi Y, Wada M, Kawanami T, Kato T: Subclinical declines in the verbal fluency and motor regulation of patients with AVIM(asymptomatic ventriculomegaly with features of idiopathic NPH on MRI): a case-controlled study. Inter Med. 2013; 52(15): 1687-1690

7) Yamaguchi Y, Wada M, Tanji H, Kurokawa K, Kawanami T, Tanji K, Yoneda M, Kato T: Steroid-responsive thalamic lesions accompanying microbleeds in a case of Hashimoto's encephalopathy with autoantibodies against α-enolase. Inter Med. 2013;52(11): 1249-1253

8)Susa S, Daimon M, Kato T, Maeda N: A novel G168X mutation and a recurrent 730-731delCT mutation of the porphobilinogen deaminase gene in Japanese patients with acute intermittent porphyria. Blood Cells Mol Dis. 2013; 51(2): 130-131

9)Takahashi T, Aoki M, Suzuki N, Tateyama M, Yaginuma C, Sato H, Hayasaka M, Sugawara H, Ito M, Abe-Kondo E, Shimakura N, Ibi T, Kuru S, Wakayama T, Sobue G, Fujii N, Saito T, Matsumura T, Funakawa I, Mukai E, Kawanami T, Morita M, Yamazaki M, Hasegawa T, Shimizu J, Tsuji S, Kuzuhara S, Tanaka H, Yoshioka M, Konno H, Onodera H, Itoyama Y: Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B. J Neurol Neurosurg Psychiatry. 2013; 84(4): 433-440

10)Daimon M, Sato H, Kaino W, Tada K, Takase K, Karasawa S, Wada K, Kameda W, Susa S, Oizumi T, Kayama T, Muramatsu M, Kato T: Association of the G-protein β3 subunit gene polymorphism with the incidence of cardiovascular disease independent of hypertension:the Funagata study. J Hum Hypertens. 2013; 27(10): 612-616

11)Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, Aida Y, Kishi H, Nunomiya K, Nakano H, Sato M, Sato K, Kimura T, Nemoto T, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I: Relationship between plasma fibrinogen levels and pulmonary function in the japanese population: the Takahata Study. Int J Med Sci. 2013; 10(11): 1530-1536

12)Suzuki T, Tsunoda-Kubota M, Aoyama J, Futami-Suda S, Hashimoto M, Igari Y, Watanabe K, Kigawa Y, Nakano H, Oba K: What characteristics at baseline are associated with the glucose-lowering effect of colestimide in patients with type 2 diabetes and hypercholesterolemia according to response to treatment? J Nippon Med Sch. 2013; 80(3): 211-217

13)Ohara M, Watanabe K, Suzuki T, Sekimizu K, Motoyama M, Ishii K, Sawai K, Nakano H, Oba K, Mizuno K: Improving in the fasting, but not the postprandial, glucose level is associated with reduction of plasma d-ROMs level in patients with type 2 diabetes. J Nippon Med Sch. 2013; 80(3): 200-210

14)Ouchi M, Oba K, Aoyama J, Watanabe K, Ishii K, Yano H, Motoyama M, Sekimizu K, Matsumura N, Igari Y, Suzuki T, Nakano H: Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus. Clin Biochem. 2013; 46(15): 1436-1441

15)Watanabe K, Ohara M, Suzuki T, Ouci M, Suzuki K, Hashimoto M, Saigusa T, Aoyama J, Nakano H, Oba K: Aortic arch calcification detectable on chest X-ray films is associated with plasma diacron-reactive oxygen metabolites in patients with type 2 diabetes but without cardiovascular disease. J Nippon Med Sch. 2013; 80(6): 410-419

16)Okada H, Wada M, Sato H, Yamaguchi Y, Tanji H, Kurokawa K, Kawanami T, Takahashi T, Kato T: Neuromyelitis optica preceded by hyperCKemia and a possible association with coxsackie virus group A10 infection. Intern Med. 2013; 52(23): 2665-2668

17)Sato H, Takahashi Y, Wada M, Shiono Y, Suzuki I, Kohno K, Kato Y, Kawanami T, Sakurada K, Kayama T, Kato T: Lymphomatosis cerebri with intramedullary spinal cord involvement. Intern Med. 2013; 52(22): 2561-2565

18)Mitsui J, Matsukawa T, Ishiura H, Fukuda Y, Ichikawa Y, Date H, Budrul Ahsan B, Nakahara Y, Momose Y, Takahashi Y, Iwata A, Goto J, Yamamoto Y, Komata M, Shirahige K, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Takashima H, Satake W, Toda T, Kuwano R, Watanabe H, Ito M, Sobue G, Soma H, Yabe I, Sasaki H, Aoki M, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Yasui K, Nakashima K, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Dürr A, Brice A, Filla A, Klockgether T, Wüllner U, Nicholson G, Gilman S, Shults CW, Tanner CM, Kukull WA, Lee VMY, Masliah E, Low PA, Sandroni P, Trojanowski JQ, Ozelius L, Foroud T, and Tsuji S： Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med. 2013; 369(3): 233-244

19)Takahashi M, Obayashi M, Ishiguro T, Sato N, Niimi Y, Ozaki K, Mogushi K, Mahmut Y,Tanaka H, Tsuruta F, Dolmetsch R, Yamada M, Takahashi H, Kato T, Mori O, Eishi Y, Mizusawa H, Ishikawa K: Cytoplasmic location of α1A voltage-gated calcium channel C-terminal fragment(Cav2.1-CTF)aggregate is sufficient to cause cell death. PLoS One. 2013; 8(3): e50121

20)猪狩龍佑，和田学，佐藤裕康，林由起子，西野一三，加藤丈夫: 運動ニューロン疾患の臨床像を呈し、VCP遺伝子変異が明らかになったinclusion body myopathy with Paget's disease of bone and frontotemporal dementia(IBMPFD)の1例．臨床神経学．2013; 53(6): 458-464

21)伊関千書，高橋賛美，和田学，川並透，鈴木匡子，加藤丈夫: 多様な課題が含まれる「宿題帳」を継続することで農村地域住民の語の流暢性が向上した―自治体主催の介護予防事業の有用性と評価法の検討．Dementia Japan. 2013; 27(1): 62-69

(2)  総説

1)Sato H, Kato T, Arawaka S: The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Pakinson’s disease: a review of in vivo models. Rev. Neurosci. 2013; 24(2): 115-23

2)Kato T, Takahashi Y, Kawanami T: Familial normal pressure hydrocephalus: a novel subgroup. J Neurol Transl Neurosci. 2013; 1: 1008

3)山口佳剛，加藤丈夫: 膠原病と関連する認知症. Modern Physician. 2013; 33(1): 30-33

4)丹治治子: iPS細胞は、今後の神経難病の診療にどのように関わってくるのでしょうか．JALSAやまがた．2013; 52: 28-31

5)丹治治子，川並透，加藤丈夫：リケッチア感染症　オリエンチャツツガムシ.神経症候群（第2版）Ⅰ.2013;722-724

6)佐藤裕康，加藤丈夫：リケッチア感染症　発疹チフス.神経症候群（第2版）Ⅰ.2013；714-717

7)高橋賛美，加藤丈夫：リケッチア感染症　紅斑熱群リケッチア.神経症候群（第2版）Ⅰ.2013；718-721

8)川並透：悪性腫瘍と脳血管障害（Trou sseau 症候群含む）.神経症候群（第2版）Ⅰ,2013；509-513

9)荒若繁樹,加藤丈夫：α-synuclein（PARK1/4）機能における翻訳後修飾の役割.医学のあゆ　       み.2013;247(10):1003-1008

(3)  著書

1)川並透，加藤丈夫:筋痙攣とミオグロビン尿症．内科学　第10版．朝倉書店, 2013: 2344-2346

2)亀田亘， 加藤丈夫：内科疾患に伴う神経障害　糖尿病. 水澤英洋，鈴木則宏他，今日の神経疾患治療指針　     第2版．東京；医学書院, 2013：1004-1010

3)加藤丈夫：代謝性疾患：遺伝性セルロプラスミン欠損症．小川聡．内科学書　第8版．東京；中山書店，2013：375-376

4)荒若繁樹，加藤丈夫：代謝性疾患：ビタミン代謝異常．小川聡．内科学書　第8版．東京；中山書店，2013：376-380

5)川並透，加藤丈夫：内科的疾患に伴う神経症状：内分泌・代謝疾患．小川聡．内科学書　第8版．東京；中山書店，2013：393-394

6)栗田啓司，加藤丈夫：内科的疾患に伴う神経症状：血液疾患．小川聡．内科学書　第8版．東京；中山書店，2013：395-396

7)佐藤裕康，加藤丈夫：ALSに対するリハビリテーション．辻省次，祖父江元．すべてがわかるALS・運動ニューロン疾患．東京；中山書店，2013：323-328

(4)  その他

1)加藤裕一，高野桂，鈴木郁子，塩野洋介: 派遣先の基幹病院での投与で継続診療を実現　患者の状態に合わせて臨機応変に役割分担．ITP治療連携レポート．2013

2)大本英次郎，佐藤伸二，木村淳，加藤裕一，本間りこ: Current Status and Future Perspectives in the Treatment for Ph+ALL. Hematology Today 特別企画Ⅶ．2013; 2-9